Reduction of Cardiovascular Events with EPA-Intervention trial04/01/2012 - 12/31/2017 (PI)
Amarin Pharma Inc.
A Multicenter, Randomized, Double-Blind Placebo-Controlled Study to Evaluate Cardiovascular Outcomes Following Treatment06/01/2010 - 12/31/2013 (PI)
Takeda Pharmaceuticals North America, Inc.
A Multicenter, Double-Blind, Randomized Study to Establish the Clinical Benefit and Safety of Vytorin vs. Simvastatin Monotherapy in High-Risk Subjects Presenting with Acute Coronary Syndrome (IM01/19/2006 - 12/31/2012 (PI)
Schering-Plough Research Institute
Placebo-Controlled, Double Blind, Randomized, Multi-center Study to Assess the Effects of Dronedarone 400mg BID on Cardiac Geometry & Function in Patients with Atrial Fibrillation & Left Atrial etc05/01/2011 - 06/30/2012 (PI)
Sanofi-Aventis, U.S., LLC
Placebo-Controlled, Double Blind, Randomized, Multi-center Study to Assess the Effects of Dronedarone 400mg BID on Cardiac Geometry & Function in Patients with Atrial Fibrillation & Left Atrial etc05/01/2011 - 06/30/2012 (PI)
Sanofi-Aventis, U.S., LLC
A Placebo-Controlled, Double-Blind, Randomized, Multi-center Study to Asses the Effects of Dronedarone 400mg BID on Cardiac Geometry and Function in patients with Atrial Fibrillation and Left Atrial Enlargement05/01/2011 - 06/30/2012 (PI)
Sanofi-Aventis, U.S., LLC
Aquavit (DFI4510)10/01/2001 - 12/31/2004 (PI)
Sanofi Synthelabo Research
Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events06/01/2003 - 05/31/2004 (PI)
Bristol-Myers Squibb
Study in Patients Preventing with Acute Coronary Syndromes08/01/2001 - 07/31/2003 (PI)
Aventis Pharmaceuticals Inc